NIH R01 · 2025
In recent years, aggregate 5-year survival after childhood cancer surpassed 85% and at least 500,000 individuals living in the US are childhood cancer survivors (CCS). Unfortunately, treatment-related late effects occur in more than two thirds of CCS and in half are severe or life-threatening, with a steadily rising cumulative incidence that results in premature mortality, excess morbidity, psychosocial distress, and lower quality of life. Given this life-long burden, formal transition of survivorship care from pediatric to adult-focused providers is recommended for CCS to ensure continuation of medically and developmentally appropriate management over the life span. Despite this, use of…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.